- Enhanced Recovery after Surgery (Eras) and Immunonutrition: An Evidence-based Approach
- Redhill Biopharma Extends Talicia® Unrestricted National and Regional Commercial Coverage to over 40 Million Additional Americans
- Fujifilm Earns Fda “breakthrough Device” Designation for Endosurgical Image Enhancement Technology
- Cognitive Deficit and White Matter Changes in Celiac Disease
- Family History of Colorectal Cancer and Prevalence of Advanced Colorectal Neoplasia in Screening
- Enhanced Recovery after Surgery (Eras) and Immunonutrition: An Evidence-based Approach
- Redhill Biopharma Extends Talicia® Unrestricted National and Regional Commercial Coverage to over 40 Million Additional Americans
- Fujifilm Earns Fda “breakthrough Device” Designation for Endosurgical Image Enhancement Technology
- Cognitive Deficit and White Matter Changes in Celiac Disease
- Family History of Colorectal Cancer and Prevalence of Advanced Colorectal Neoplasia in Screening
- Enhanced Recovery after Surgery (Eras) and Immunonutrition: An Evidence-based Approach
- Redhill Biopharma Extends Talicia® Unrestricted National and Regional Commercial Coverage to over 40 Million Additional Americans
- Fujifilm Earns Fda “breakthrough Device” Designation for Endosurgical Image Enhancement Technology
- Cognitive Deficit and White Matter Changes in Celiac Disease
- Family History of Colorectal Cancer and Prevalence of Advanced Colorectal Neoplasia in Screening

- This event has passed.
Recent Advances in Gastroenterology/Hepatology
September 14, 2019
This course is designed to update both practicing primary care providers and specialists in the latest advances in gastroenterology and will provide an overview on the clinical management of patients in a wide variety of areas including esophageal diseases, functional bowel disorders, inflammatory bowel disease, gastrointestinal malignancy, viral hepatitis, work-up of abnormal liver function tests, and colon cancer screening.
6 AMA PRA Category 1 Credits™ – maximum